WebMar 16, 2024 · The DETERx technology platform is designed to provide extended-release delivery, unique abuse-deterrent properties, and flexible dose administration options. About Xtampza ER Xtampza ® ER is Collegium’s first product … WebCollegium (NASDAQ: COLL) is a specialty pharmaceuticals company focused on developing and commercializing abuse-deterrent products to address the growing problems associated with non-medical use, abuse, and misuse of prescription products. The company's products are based on its proprietary DETERx® technology platform, which protects against …
TREND TECH SOLUTIONS - 10 Photos & 46 Reviews - Yelp
WebJan 10, 2024 · The DETERx technology platform is designed to provide extended-release delivery, unique abuse-deterrent properties, and flexible dose administration options. About Xtampza ER. Xtampza® ER is Collegium’s first product utilizing the DETERx technology platform. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of … WebThe DETERx oral drug delivery technology is designed to provide extended-release delivery, unique abuse-deterrent properties, and flexible dose administration options. For more information, visit www.collegiumpharma.com. Total Page Views: 987. VIDEO SPOTLIGHT . COMPANY PROFILES. siam cement group address
Collegium Pharmaceutical, Inc. Announces Positive Topline Results …
WebDec 1, 2010 · Collegium will focus its efforts on the continued development of its patented DETERx™ Technology. DETERx™ is a proprietary, tamper resistant, extended release delivery platform that can be applied to drugs prone to abuse, as well as drugs that have a narrow therapeutic window in which the inadvertent destruction of the time release … WebFeb 26, 2015 · The DETERx technology platform is covered by U.S. and foreign patents and patent applications. Xtampza ER ( oxycodone extended-release capsules) is the first of a number of Collegium product ... WebDETERx technology is engineered for manipulation resistance However, abuse ot Xtampza ER by injection and by nasal and oral routes ot administration is still possible siamchai knowledge